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ABSTRACT 
 
Objective: To summarise evidence on the attributable risk of infertility following 
chlamydial infection in women by performing a systematic review.  
 
Methods: Twelve databases were searched, limited to peer-reviewed papers 
published from January 1970 until September 2007. Conference abstracts and 
reference lists from reviews published since 2000 and from key articles were hand-
searched. Studies were selected for review if they met the following criteria: (i) the 
study population comprised females of child-bearing age (defined as 15-45 years) 
and incorporated a comparison group of women documented as ‘chlamydia 
negative’; (ii) the study outcomes included either infertility or successful pregnancy; 
and, (iii) the study design was one of the following: cohort, randomised controlled 
trial, ‘before and after’ studies, screening trials and systematic reviews. Studies were 
excluded if they described genital infections that either did not include Chlamydia 
trachomatis or described genital chlamydial co-infection, where no data were 
available for Chlamydia trachomatis infection alone.  
 
Results:  3349 studies were identified by the search. One study satisfied the 
inclusion criteria, a longitudinal investigation measuring pregnancy rates in 
adolescent females with and without current chlamydial infection at baseline. This 
study reported no significant difference in subsequent pregnancy rates, however, it 
had serious methodological limitations, which restrict its conclusions.   
 
Conclusions: Our systematic review demonstrates the absence of valid evidence on 
the attributable risk of post-infective tubal factor infertility following genital chlamydial 
infection. Our findings contribute empirical data to the growing debate surrounding 
prior assumptions about the natural history of chlamydial infection in women.  
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INTRODUCTION 
 
Concerns about the public health impact of genital chlamydial infection have 
generated considerable policy interest in the UK; a National Chlamydia Screening 
Programme is currently being implemented throughout England and national 
guidelines on chlamydial infection have also been widely adopted in Scotland.1-3 
Proactive targeted screening for chlamydial infection has been justified by four 
attributes of chlamydial infection; its high general population prevalence (recently 
estimated at 3% in UK residents aged under 25 years);4 its substantial transmission 
potential;5 the recent development of simple, non-invasive tests;2,5 and its potential 
for acute and chronic morbidity.5,6  
 
In this last respect, however, the evidence base appears weak; although numerous 
case control studies have reported an association between serological evidence of 
prior chlamydial infection and tubal infertility, this evidence is of limited value, for two 
reasons. First, case control studies have to rely on serological methods for 
ascertainment of prior genital Chlamydia trachomatis infection; serological methods 
(before the advent of peptide-based, species-specific assays) are universally 
acknowledged to exhibit poor validity and reliability for this purpose.7 Second, case 
control studies generate ratio measures rather than absolute measures of effect. 
Although ratio measures can demonstrate an association between chamydial 
infection and infertility, they cannot directly quantify the excess risk of infertility 
attributable to chlamydial infection, which is the crucial information required to 
counsel patients and, at a population level, to estimate the proportion of infertility 
cases that might be averted by chlamydia screening programmes. In addition, the 
control populations are often selected from very different populations (notably 
pregnant women) which may give a falsely low estimate of infertility in the unexposed 
 3
group and thus, an exaggerated estimate of the effect of chlamydial infection on 
infertility.  
 
Quantifying excess (or attributable) risk is fundamentally important at many levels; 
individual women diagnosed with apparently uncomplicated chlamydial infection 
frequently request prognostic information on their subsequent risk of infertility and 
policymakers need robust cost effectiveness evidence to underpin prevention 
strategies. One of us (LW) recently reviewed patient information materials used by 
Genitourinary Medicine (GUM) clinics across the UK; almost invariably, these 
contained no information on quantitative infertility risk, despite the importance of this 
issue to women diagnosed with chlamydial infection.8 We therefore conducted a 
systematic review of the literature to summarise existing evidence on the attributable 
risk of infertility following chlamydial infection.  
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METHODS 
 
The review question  
The review sought to answer the following question: ‘What is the attributable risk of 
infertility following one or more episodes of genital Chlamydia trachomatis infection in 
women of reproductive age?’ Attributable risk is defined as the proportion of women 
infected with Chlamydia trachomatis who subsequently develop infertility attributable 
to the chlamydial infection.  
 
Search terms, databases and search strategy  
A search strategy was developed in collaboration with information scientists at the 
Centre for Reviews and Dissemination, University of York, UK (Web Table). 
 
A comprehensive list of databases was searched, with appropriate adaptation of the 
key words for each database search (Table 1). The search was limited to published 
peer-reviewed papers from January 1970 until September 2007; the earlier time 
boundary was selected because it was judged to reflect the earliest time point from 
which diagnostic methods for chlamydial infection became available.  
 
Although this was primarily a systematic review of peer-reviewed literature, 
conference abstracts were also searched, using the 'Inside Conferences' and 'Biosis 
Previews' electronic databases to September 2004. Reference lists from reviews 
published since 2000 and from key articles were hand-searched to identify any 
further relevant papers. We did not personally contact researchers to identify ongoing 
research studies or unpublished reports; non-English language papers were not 
included in the review, as our resources would not have supported their translation.  
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Inclusion and exclusion criteria 
Studies were selected for review if they met the following criteria: (i) the study 
population comprised females of child-bearing age (defined as 15-45 years) and, in 
addition to women with genital chlamydial infection, also incorporated a comparison 
group of women documented as uninfected with Chlamydia trachomatis; (ii) the study 
outcomes included either infertility (defined as failure of a couple to achieve 
pregnancy despite 12 months of regular unprotected sexual intercourse and/or 
referral to a specialist infertility service) or successful pregnancy; and, (iii) the study 
design was one of the following: cohort, randomised controlled trial, ‘before and after’ 
studies, screening trials (where information on outcomes are given) and systematic 
reviews.  
 
Conversely, studies were excluded if: (i) the study population comprised females 
under 15 years or older than 45 years; (ii) they described genital infections that either 
did not include Chlamydia trachomatis or described genital chlamydial co-infection, 
where no data were available for Chlamydia trachomatis infection alone; (iii) they 
focused on pelvic inflammatory disease only and data on one of the outcomes 
described in the inclusion criteria were unavailable.  
 
The first reviewer scanned the abstracts and titles using the criteria described above 
and categorised them into two libraries: ‘papers for further analysis’ and ‘papers not 
relevant’. The former consisted of abstracts of original articles, reviews, and titles, for 
which no abstract was available, but which incorporated key words relevant to the 
study. To assess reliability, a second reviewer evaluated a 10% random sample of 
both libraries. Following resolution of any differences, both reviewers agreed on 
those abstracts or titles for which full papers were retrieved and the papers to be 
included in the review. 
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Study Quality Assessment 
Papers selected for review were assessed for methodological quality by the two 
reviewers using the criteria described by Levine et al.9   
 
 
 7
RESULTS 
  
Twelve databases were searched for relevant articles, generating a library of 3349 
abstracts and titles for review. Fifty papers were identified as potentially relevant to 
the research question; these included nine primary research papers, ten review 
articles published since 2000 and 31 papers retrieved from the ‘title only’ group. Of 
these 50 selected papers, forty-nine failed to satisfy the inclusion criteria; 33 were 
review or review-type articles and not primary research studies, eight articles did not 
address the outcome of interest and eight were not an appropriates study design. 
One additional paper was identified from a review paper but this was also rejected on 
the basis of study design.10 (Figure 1)  
 
The one study which satisfied the inclusion criteria was a longitudinal investigation, 
measuring pregnancy rates in adolescent females with and without evidence of 
current chlamydial infection at baseline; no statistically significant difference in 
pregnancy rates at the end of the follow-up period was found (Table 2).11 However, 
the study’s methodological limitations diminish the precision of its statistical estimates 
and the overall validity of its conclusions, further discussed below.  
 
First, the study was conducted in Indianapolis, USA between 1985 and 1990, at a 
time when the gold standard laboratory diagnostic test (tissue culture) was relatively 
insensitive. This is likely to have resulted in incorrect misclassification of a proportion 
of chlamydia infected women into the ‘uninfected’ group at the study outset.  
 
Second, the sample size afforded limited statistical power, compounded by 
substantial attrition of the study population, with only 104 (21%) of the original cohort 
of 496 women available for participation in the follow-up telephone survey. There was 
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uncertainty about the mean follow-up time and whether this differed between the 
three study groups.  
 
Third, measurement and analysis of confounding variables (including age, socio-
economic circumstances, contraceptive use, frequency of intercourse and number of 
sexual partners) were inadequate.  
 
Crucially, more than half of the overall survey sample reported current contraceptive 
use (oral contraception, condoms or both); however, pregnancy outcomes were, 
however, neither stratified by contraceptive use nor analysed by multivariable 
modelling methods to investigate the confounding effects of contraceptive use on 
pregnancy outcomes. 
  
In summary, Katz et al found no association between a history of treated chlamydial 
infection and infertility in their study population, but the caveats described above 
seriously limit these conclusions. As no other eligible studies could be located in our 
systematic review, it was not possible to obtain valid evidence on the attributable risk 
of infertility following genital chlamydial infection in women. 
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DISCUSSION 
 
In summary, our systematic review demonstrates the absence of valid evidence on 
the attributable risk of infertility following genital chlamydial infection and an overall 
dearth of research on the natural history of chlamydial infection in women.  
 
Although an extensive search for evidence was systematically conducted, we 
acknowledge that our study does have limitations; researchers in the field were not 
personally contacted about any unpublished research studies and non-English 
language papers were not included in the review. However, the authors have 
sufficient awareness of current health services research on chlamydia testing policy 
to be satisfied that this boundary (selected for pragmatic reasons) was unlikely to 
have introduced bias.  
 
To our knowledge, this is the first published systematic review of the evidence base 
on attributable risk of infertility following genital chlamydial infection. While the focus 
of our study was to examine the attributable risk of genital chlamydial infection, we 
fully recognise the polymicrobial nature of pelvic inflammatory disease (PID) and 
thus, subsequent infertility. Accordingly, we defined our exclusion criterion to select 
only studies where data were available on genital chlamydial infection, even in those 
with concurrent infections.  
 
Genital chlamydial infection has been judged to fulfil the required criteria for 
establishment of a screening programme.12 This judgment was, however, based on 
assumptions about the natural history of infection that are now being increasingly 
questioned. Indeed, there are still many unanswered questions regarding the 
persistence of chlamydial infection; in a one-year follow up study a 45% clearance 
rate of infection per year was found in women who had received no antibiotic 
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treatment; in addition, none of the women developed clinical PID.13 However, 
distinguishing between persistent infection and re-infection may be difficult also.  
 
Our systematic review advances the current debate about the potential health 
benefits that may be gained from chlamydia screening by demonstrating empirically 
the lack of evidence on attributable risk.14-18 Data from two randomised control trials 
of screening versus no screening or normal care demonstrated a greater than 50% 
decrease in the incidence of PID.19,20  However, these have since been criticised 
because of the considerable potential for both selection and measurement bias. 
Scholes et al analysed outcomes in only a small proportion of the women 
randomised and ascertainment of the main outcome measure (PID) was made by 
case note review (as opposed to laparoscopic diagnosis or use of systematic, 
criterion-based clinical examination). 19 In addition, the study did not evaluate an 
opportunistic approach to screening, which is the current strategy being advocated in 
the UK and in most other countries. In the study by Ostergaard et al there was a high 
level of loss to follow up of botht eh screening and the control group and possible 
under-reporting of PID and it was unclear what effect these may have had on the 
screening trial. 20  Recent key contributors to this debate include van Valkengoed et 
al and Low et al.16,18 Van Valkengoed et al generated modelled estimates of the risk 
of tubal factor infertility at 0.02%, substantially lower than previous estimates which 
have ranged between 1.5 and 16%.16 The authors concluded that current 
assumptions over-estimate the probability of complications and accordingly the 
health gain and cost savings associated with chlamydia screening. Low et al 
presented data from a 15 year follow up of a retrospective population-based cohort of 
women (aged less than 25 in 1985) in Uppsala, Sweden. They estimated the 
cumulative incidence of infertility at between 3-7% depending on whether the woman 
had ever tested or ever been diagnosed with chlamydia and concluded that this was 
lower than expected from previous published estimates.14,18 Thus, there is a growing 
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body of published data which suggest that the reduction in reproductive morbidities 
resulting from chlamydia screening programmes may be over-estimated and that 
further research is required.  
 
This review has highlighted the absence of high quality evidence to answer questions 
commonly posed by the increasing numbers of women daily who receive a diagnosis 
of lower genital tract chlamydial infection within proactive opportunistic screening 
programmes in the UK and elsewhere. Current evidence is unable to provide women 
with any reliable estimates of the likelihood of serious reproductive health 
complications. At a wider population level, because the absolute risk of infertility 
following chlamydial infection is unknown, policymakers find themselves similarly ill-
equipped to quantify the population impact of chlamydial infection on reproductive 
morbidity, and therefore face uncertainty about the proportion of PID and infertility 
that is preventable by chlamydia screening. 
 
There are a number of possible approaches to address the major gap in the evidence 
base. The optimal epidemiological method, a cohort study design, for estimating the 
absolute risk of infertility attributable to chlamydial infection would now be considered 
unethical; it would require an extensive follow-up period in untreated women, careful 
measurement and control of potential confounding variables (including age, 
contraceptive usage, socio-economic circumstances and sexual behaviour) and 
accurate measurement of infertility/successful pregnancy outcomes. This 
necessitates an extremely large sample size and, accordingly, considerable 
resources. It would also be extremely difficult to gain ethical approval for a cohort 
study designed to monitor adverse outcomes among women with untreated 
chlamydial infection within a policy context that actively promotes testing and 
treatment.21 There is already good evidence that treating people with genital 
chlamydial infection is beneficial in relation to short term morbidity, such as urethritis 
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or epididymitis;2,5 moreover, numerous case control studies have demonstrated that 
women with infertility have a significantly greater chance of having been infected with 
chlamydia than those who are fertile.5,6 What remains unknown, however, is the 
absolute magnitude of the increased risk of infertility that is attributable to Chlamydia 
trachomatis infection. 
 
If undertaking a cohort study is not feasible, remaining options for estimation of 
attributable risk would involve statistical modelling of the risk of progression to pelvic 
inflammatory disease following chlamydial infection. With this methodological 
approach, assumptions about the polymicrobial aetiology of PID and other dynamic 
transmission-related factors that may influence the outcome of chlamydial infection 
could be factored into the analysis. Alternatively, ecological analyses comparing 
nations or regions might offer useful insights.22 Such an analysis might involve 
comparing reproductive data from countries with differing approaches to screening 
policy. The resulting data will ensure that the future direction of chlamydia screening 
programmes in the UK and elsewhere is based on the best available evidence.  
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Key messages 
1. This systematic review demonstrates an absence of evidence on the 
attributable risk of infertility following genital chlamydial infection and an 
overall lack of research on the natural history of chlamydial infection in 
women.  
2. Only one primary research study was identified from the literature search; 
however, some methodological limitations resulted in its rejection from the 
review. Thus, no measure of assurance on the risk of infertility, as a result of 
a positive chlamydia diagnosis, to inform women who are undergoing 
chlamydia testing, could be made from this research. 
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3. Chlamydia screening programmes are based on previous assumptions about 
the natural history of infection, in particular the likelihood of developing 
infertility. Most of this evidence is derived from case-control studies or those 
based on hospital and clinic-based populations - these are inappropriate 
types of study from which to provide a level of the risk of developing infertility 
following chlamydial infection.  
4. This study, in combination with other recent publications, indicates that the 
previous assumptions on progression rates to infertility are no longer valid.  
5. The proportion of pelvic inflammatory disease and infertility that is 
preventable by chlamydia screening remains unknown.  
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Web Table: Search terms and strategy used for searching Medline database 
 
Search terms 1. Woman/Women/Female 
2. Chlamydia trachomatis / Chlamydia infections 
3. Infertility 
 - tubal factor infertility 
 - impaired fertility 
4. Pregnancy 
 - pregnancy outcome  
5. Chlamydia heat shock protein 
6. Anti-chlamydial antibodies 
 
Search Strategy 
MEDLINE 1966 – Sept 
week 2 2007 (Ovid 
interface) 
 
1. chlamydia trachomatis/ 
2. chlamydia infections/ 
3. (chlamydia$ adj2 (infection$ or trachoma$)).ti,ab.  
4. 1 or 2 or 3 
5. chlamydia pneumoniae/  
6. 4 not 5  
7. exp women/  
8. female/  
9. (woman or women or female$).ti,ab. 
10. or/7-9  
11. exp infertility/  
12. (infertil$ or subfertil$ or sub-fertil$).ti,ab.  
13. ((tubal$ or tube$) adj2 (fertil$ or infertil$ or subfertil$ or 
factor$ or conceiv$ or conception$ or pregnan$)).ti,ab.  
14. ((impair$ or problem$ or difficult$ or substandard$ or sub-
standard$ or inabilit$) adj2 (conceiv$ or conception$ or 
pregnan$ or fertil$ or infertil$)).ti,ab.  
15. chlamydia$ heat shock protein$.ti,ab.  
16. ((antichlamydia$ or anti chlamydia$) adj2 (antibod$ or anti 
bod$)).ti,ab.  
17. pregnancy/  
18. pregnancy outcome/  
19. pregnan$.ti,ab.  
20. or/11-19 
21. 6 and 10 and 20 
22. animals/ 
23. human/  
24. 22 not (22 and 23) 
25. 21 not 24 
26. (comment or letter or editorial).pt. 
27. 25 not 26 
28. limit 27 to yr=1970 – 2007 
 
 
 19
Table 1: Databases and time periods searched. 
 
Database Date(s) searched and (system used)  
MEDLINE  1966 – September Week 2, 2007, (OVID) 
Embase  1980 - wk 38 2007 (OVID) 
CINAHL  1982 – September week3, 2007 (OVID) 
Health Management Information 
Consortium (HMIC)  
September 2004 edition, (OVID) 
Cochrane Database of Systematic 
Reviews (CDSR) 
Cochrane Library 2004, issue 3 (http://www.update-
software.com/clibng/cliblogon.htm) 
Database of Abstracts of Reviews of 
Effectiveness (DARE) 
18/10/04 CRD administration database 
Health Technology Assessment 
database 
18/10/04 CRD administration database 
National Research Register (NRR)  Issue 3, 2004 
 http://www.update-software.com/National/ 
Popline Updated 18/10/04 
(http://db.jhuccp.org/popinform/basic.html) 
Science Direct 1970-2004 (http://www.sciencedirect.com/)  
Inside Conferences 1993- October 2004 Oct (Dialog) 
Biosis Previews 1993-October 2004 Oct (Dialog) 
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Figure 1: Synopsis of process and results of the systematic review. 
 
 Library compiled containing 3349 references: 
abstracts (n=2649) and titles only (n=700)  
1
Library scanned for inclusion of papers in review 
Reviewer 1 – whole dataset 
Reviewer 2 – 10% sample 
2891 papers excluded: not 
relevant for further analysis on 
basis of title or review of abstract
1 paper retrieved for detailed 
evaluation 
                                            
* Articles which did not meet the inclusion criteria were excluded for the following reasons: 33 
papers were review or review-type articles and not primary research studies (one additional 
paper was identified from reading these articles but this was rejected on the basis of an 
inappropriate study design); eight did not address the outcomes of interest and eight were not 
an appropriate study design.  
458 papers for further analysis 
240 abstracts 66 reviews 152 title only
50 potentially relevant papers identified and screened
  
 10 reviews   31 title only 9 abstracts 
49 papers excluded 
on basis of complete 
article review*
1 additional 
paper retrieved 
and rejected*  
Study appraised;  
see Results and Table 2 
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Table 2: Characteristics, extract from the results, and summary of the primary research study.9  
 
Design and 
Participants Setting 
Outcome 
measures 
Cohort 
groups in 
follow up* 
No. (%) in 
telephone 
survey 
subgroup 
(n=104, 
21%)** 
% 
pregnant 
% live 
births Summary of study results  
Group 1: 
no 
evidence 
of 
chlamydia 
infection 
(n=319) 
64 (20) 70.3 50.0 
Group 2: 
Single 
chlamydia 
infection 
(n=109) 
21 (19) 66.7 61.9 
Group 3: 
multiple 
chlamydia 
infections 
(n=68) 
19 (28) 63.2 52.6 
Retrospective 
cohort study. 
 
Adolescent 
women enrolled 
in a chlamydia 
screening 
programme.  
 
Original cohort 
of 496 sexually 
active women 
aged between 
11 and 20 
years (mean 
age 19.7 
years). 
 
Public health 
adolescent 
clinics in 
Indianapolis, 
USA.  
 
Participants 
recruited 
between 
October 1985 
and February 
1990  
 
Telephone 
interviews 
conducted 
June-August 
1990.  
 
Follow-up 
interval: 1.5 – 
4 years 
Pregnancy 
and live 
births using:  
1.hospital 
activity data 
(from hospital 
discharge 
and 
pregnancy 
test 
performed)  
 
2. telephone 
survey – self 
reported 
pregnancy, 
data on 
sexual 
activity and 
contraceptive 
use 
Total 
(original 
cohort)  
n = 496 
p value*** 0.83 0.58 
1. No significant difference in pregnancy 
rates or live birth rates across the three 
groups after adjusting for sexual activity 
and contraceptive use (data from the 
telephone survey participants). 
 
2. Data from hospital in- and out-patient 
records during the follow-up period 
indicated that five cases of PID occurred, 
three in the uninfected group (who 
subsequently delivered live infants) and 
two in the single infection group. In this 
latter group, two ectopic pregnancies also 
occurred.  
 
3. No overall association between history 
of treated chlamydial infection and 
infertility 
 
 
*The three groups were defined based on laboratory Chlamydia trachomatis tissue culture results. Infection is diagnosed on the basis of the ability to grow Chlamydia trachomatis in tissue culture followed 
by detection of chlamydia inclusion bodies by immunofluorescence. Those with no infection had at least two negative results.   
**number and percentage of original cohort in follow up 
***p value for chi-squared test of comparison between the three groups. 
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